Alobresib (Standard)

Overview

Alobresib (Standard) is the analytical standard of Alobresib ( HY-109050 ). This product is intended for research and analytical applications. Alobresib (GS-5829) is a BET bromodomain inhibitor, which represents a highly effective therapeutics agent against recurrent/chemotherapy resistant uterine serous carcinoma (USC) overexpressing c-Myc . Alobresib can be used in the metastatic castration-resistant prostate cancer (mCRPC) research.

Application

Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Epigenetic Reader Domain

Product Information

• Catalog No.: HY-109050R
• CAS No.: 1637771-14-2
• Molecular Formula: C26H23N5O2
• Molecular Weight: 437.49
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source